cms_ME: 35
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 35 |
BARRON CENTER |
205011 |
1145 BRIGHTON AVE |
PORTLAND |
ME |
4102 |
2017-10-26 |
428 |
D |
0 |
1 |
7DKA11 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to ensure that the licensed pharmacist identify and recommend a gradual dose reduction for an antipsychotic medication, unless clinically contraindicated, for 1 of 5 stage 2 sampled residents reviewed for unnecessary medications (#55). Finding: On review of Resident #55's clinical record, the surveyor noted the resident's current physician's orders [REDACTED]. The Pharmacist's Notes to Attending Physician/Prescriber, dated 5/2/17 and 6/2/17, did not address nor recommend a gradual dose reduction for the antipsychotic. The surveyor also reviewed the Drug Regimen Review from 5/2/17 through 10/2/17, and could not determine any recommendations made for a gradual dose reduction. In an interview with the surveyor on 10/26/17 at 12:09 p.m., the Interim Administration confirmed there is no evidence of an attempted gradual dose reduction of the antipsychotic Risperidone. |
2020-09-01 |